A Randomized, Open-Label, Multi-Center, Active-Controlled Phase II Study Comparing Abiraterone Acetate Tablets (II), an Improved Formulation, Versus Originator Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer

Xiaolin Lu, Tao Dai, Xue Chen,Bin Wu, Hui Chen,Jitao Wu,Dexin Yu, Huixin Ge, Jian Li,Houbao Huang, Tiwu Fan, Linzhong Cheng,Xiaoping Zhang,Xuepei Zhang,Xin Yao, Junli Wei,Zhenqiang Xu,Wenzeng Yang,Chaohong He, Jiexin Luo,Ling Guan,Bin Fu,Qilin Wang, Xiaofeng Chen, Yongdong Zhang,Benkang Shi, Bin Zheng, Yong Wang,Hong Luo, Guoqiang Chen, Huan Wang,Quanren Wang,Dingwei Ye

BMC Medicine（2025）

引用 0|浏览3

关键词

Castration-resistant prostate cancer,Abiraterone acetate,CYP17 inhibitor,Testosterone,Prostate-specific antigen

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要